Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Sanofi India

Sector: Healthcare | Industry: Drugs & Pharma
R 6,134.00 137.75  | 2.30% 5.22% 35.77 13,908.19
NSE Price: Oct 22, 11:04 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 11:04 6,134.00 137.75 2.30% 6,009.50 5,996.25 3,017 5,925.05 - 6,134.00
BSE Oct 22, 11:14 6,125.00 24.60 0.40% 6,050.00 6,100.40 110 5,984.95 - 6,125.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 16,474 P/B: 6.24 NSE Code: SANOFI
52-Week Range: R 5,280.00 - 6,599.30 Dividend Yield: 1.39% BSE Code: 500674
TTM EPS: R 168.82 Book Value: R 968.46 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Cipla (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Sanofi India -5.87 3.32 0.99 1.33 12.25 12.67 14.17
S&P BSE Mid Cap -6.60 7.30 0.39 1.45 2.11 9.22 8.04
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of NSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 12.47 8.11 8.90
Net Profit 16.75 5.79 7.49
EPS 16.75 5.79 7.52
Book Value 9.23 10.34 10.37
Average
Operating Margin 25.74 25.41 23.98
Net Margin 13.31 12.65 12.79
Return on Networth 18.18 17.49 18.37
Return on Investment 28.76 27.55 28.02
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 4.27 9.41 2.96
Operating Profit 2.49 -2.21 15.12
Net Profit 4.84 -2.21 22.82
EPS 4.84 -2.21 22.82
TTM
Revenue 2.24 11.22 5.91
Operating Profit -0.56 4.22 2.20
Net Profit -0.56 3.85 2.15
EPS -0.56 3.85 2.15
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Sanofi India 13,908.19 2,935.40 388.80 12.84 18.18 6.24 35.77
Cipla 36,012.82 16,412.44 1,533.58 9.13 10.37 2.33 23.16
Piramal Enterprises 33,067.19 14,278.56 1,708.87 11.71 4.28 1.24 16.00
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Apr 03, 2018 Aberdeen Asset Management Asia Ltd  Sell Market 1,967 5,167.15 101.64
Jun 27, 2016 Reliance Capital Trustee Co Ltd  Sell Market 25,000 4,210.15 1,052.54
Sep 23, 2015 Aberdeen Asset Management Asia Ltd  Sell Market 7,534 4,160.75 313.47
Apr 29, 2015 Aberdeen Asset Management Asia Ltd  Sell Market 23,671 3,192.75 755.76
Feb 02, 2015 Reliance Capital Trustee Co Ltd  Sell Market 32,000 3,367.30 1,077.54
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Aditya Birla Sun Life Mutual Fund 3.363 3.678 3.605 3.485 3.447
UTI Mutual Fund 2.423 2.531 2.564 2.564 2.582
SBI Mutual Fund 1.791 1.793 2.228 2.317 2.489
L&T Mutual Fund 1.606 1.514 1.355 0.875 0.709
Nippon India Mutual Fund 1.546 1.794 2.113 2.163 2.120
ICICI Prudential Mutual Fund 0.661 0.457 0.348 0.348 0.348
Sundaram Mutual Fund 0.626 0.627 0.112 - -
Franklin Templeton Mutual Fund 0.524 0.633 0.633 1.796 1.851
Invesco Mutual Fund 0.363 0.600 0.363 0.218 0.210
Axis Mutual Fund 0.265 0.484 0.466 0.317 0.268
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Sanofi India Ltd.

Address: Sanofi House, 117-b, L&t Business Park, Saki Vihar Road, Powai, Mumbai, Maharashtra - 400072

Email: [email protected]

Website: www.aventispharmaindia.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
5.23
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
36.14
5-Years Price to Book
6.30
Earnings Yield
EBIT / Enterprise value
4.73%
PEG
Price / Earnings to growth ratio
5.25
Related Stocks
  Current Price   Chng %
Abbott India R10,599.95 -0.98%
Alkem Laboratories R1,960.00 +0.05%
Biocon R257.30 -0.83%
Cadila Healthcare R242.05 +0.58%
Cipla R446.25 +0.47%
Glaxosmithkline Pharma R1,445.00 +0.44%
Lupin R743.35 +0.58%
Pfizer R3,267.95 +1.43%
Piramal Enterprises R1,665.50 +6.98%
Torrent Pharmaceuticals R1,643.35 -2.45%
As on Oct 22, 11:04